News | June 30, 2009

Elekta Forms Fund for Cancer Care in Developing Countries

July 1, 2009 - Elekta has formed an investment company, Global Medical Investments "GMI", with Swedfund International AB for financing and establishment of cancer care projects in developing countries.

Global Medical Investments, GMI, will invest, develop and support the establishment of cancer management programs in developing countries across the world in cooperation with local healthcare providers and partners.

Through GMI, Swedfund and Elekta will be able to provide technology and competence for advanced cancer management. Elekta and Swedfund will each invest up to USD 10 M in GMI. Through this initiative Elekta will also strengthen its presence in countries where the company has limited business activities.

GMI is currently in the final stage of development of the first sophisticated radiotherapy center in Accra, Ghana. This is developed in close collaboration with Scandinavian Care Projects AB, which is leading this project, and with local partners. The cancer center is expected to initiate treatment in the first half of 2010, and will give the people in Ghana access to effective and cost efficient cancer treatment with Elekta’s latest technology.

“We believe that this investment, with Swedish expertise in healthcare and medical technology, will contribute to increased availability of advanced medical care. Swedfund participated in the financing of the first GammaKnife in Africa, which is located in Egypt, and we are very pleased by this extended cooperation which we believe will lead to many new cancer centers in developing countries," saids Björn Blomberg, managing director of Swedfund.

For more information: www.swedfund.se and www.elekta.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more